Adverum Biotechnologies, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 2.27 M | $10.59 M | 0.00% | 10.86% |
TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 1.80 M | $8.39 M | -10.55% | 8.61% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.76 M | $8.22 M | 0.00% | 8.43% |
BLACKROCK, INC. | 02/07/2025 | 1.49 M | $6.94 M | -0.36% | 7.11% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.07 M | $4.99 M | 0.00% | 5.12% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 541,666 | $2.53 M | 0.00% | 2.59% |
VERSANT VENTURE MANAGEMENT, LLC | 02/12/2025 | 506,821 | $2.37 M | 0.00% | 2.43% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 442,490 | $2.07 M | 0.78% | 2.12% |
STATE STREET CORP | 02/14/2025 | 369,554 | $1.73 M | -0.02% | 1.77% |
PALE FIRE CAPITAL SE | 02/13/2025 | 315,154 | $1.47 M | 2.20% | 1.51% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 287,246 | $1.34 M | 0.00% | 1.38% |
REGENERON PHARMACEUTICALS, INC. | 02/07/2025 | 180,909 | $844,845 | 100.00% | 0.87% |
NORTHERN TRUST CORP | 02/14/2025 | 152,577 | $712,534 | -1.56% | 0.73% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 129,605 | $605,255 | 249.60% | 0.62% |
MARSHALL WACE, LLP | 02/13/2025 | 98,027 | $457,787 | 128.52% | 0.47% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 95,997 | $448,306 | 167.89% | 0.46% |
GRANT/GROSSMENDELSOHN, LLC | 01/15/2025 | 84,173 | $393,088 | 117.95% | 0.40% |
FMR LLC | 02/13/2025 | 57,903 | $270,407 | -75.33% | 0.28% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 43,576 | $203,500 | 16.26% | 0.21% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 42,847 | $200,095 | 46.54% | 0.21% |
CORTON CAPITAL INC. | 02/14/2025 | 32,696 | $152,690 | 100.00% | 0.16% |
QUINN OPPORTUNITY PARTNERS LLC | 02/13/2025 | 26,829 | $125,291 | 0.00% | 0.13% |
CITIGROUP INC | 02/12/2025 | 19,987 | $93,339 | 31.94% | 0.10% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 18,261 | $85,279 | 38.30% | 0.09% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 16,277 | $76,014 | 36.61% | 0.08% |
CANTOR FITZGERALD, L. P. | 02/14/2025 | 15,446 | $72,133 | 0.00% | 0.07% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 12,072 | $56,376 | 4.61% | 0.06% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 10,343 | $48,302 | -7.01% | 0.05% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 4,362 | $20,371 | 178.01% | 0.02% |
02/11/2025 | 4,182 | $19,530 | 100.00% | 0.02% | |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 1,797 | $8,392 | 0.00% | 0.01% |
AMALGAMATED BANK | 02/04/2025 | 720 | $3,000 | 0.00% | 0.00% |
01/23/2025 | 710 | $3,316 | 100.00% | 0.00% | |
STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 707 | $3,302 | 971.21% | 0.00% |
ALLWORTH FINANCIAL LP | 01/30/2025 | 102 | $456 | 5,000.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 90 | $420 | 4.65% | 0.00% |
02/06/2025 | 85 | $397 | 100.00% | 0.00% | |
02/14/2025 | 44 | $205 | 100.00% | 0.00% | |
GAMMA INVESTING LLC | 01/03/2025 | 31 | $145 | -89.60% | 0.00% |
GHP INVESTMENT ADVISORS, INC. | 01/27/2025 | 20 | $94 | 0.00% | 0.00% |
FRAZIER FINANCIAL ADVISORS, LLC | 02/12/2025 | 1 | $5 | 0.00% | 0.00% |
ZACKS INVESTMENT MANAGEMENT | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
VR ADVISER, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SQUAREPOINT OPS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
VIVO CAPITAL, LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Adverum Biotechnologies, Inc. institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of Adverum Biotechnologies, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 2.27 M
TCG Crossover Management, LLC: 1.8 M
FRANKLIN RESOURCES INC: 1.76 M
BlackRock, Inc.: 1.49 M
Frazier Life Sciences Management, L.P.: 1.07 M
5AM Venture Management, LLC: 541,666
69.67% of Adverum Biotechnologies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.58 M shares in the last 24 months. This purchase volume represents approximately $98.50 M in transactions.